FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIOANALYTICAL SYSTEMS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<TABLE>
<CAPTION>
<S> <C>
INDIANA. . . . . . . . . . . . . . . . . 35-1345024
(STATE OF INCORPORATION. . . . . . . . . (I.R.S. EMPLOYER
OR ORGANIZATION) . . . . . . . . . . . . IDENTIFICATION NO.)
2701 KENT AVENUE
WEST LAFAYETTE, INDIANA. . . . . . . . . 47906
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
</TABLE>
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT: NONE
IF THIS FORM RELATES TO THE REGISTRATION OF A CLASS OF SECURITIES
PURSUANT TO SECTION 12(B) OF THE EXCHANGE ACT AND IS EFFECTIVE PURSUANT TO
GENERAL INSTRUCTION A.(C), CHECK THE FOLLOWING BOX:
IF THIS FORM RELATES TO THE REGISTRATION OF A CLASS OF SECURITIES PURSUANT TO
SECTION 12(G) OF THE EXCHANGE ACT AND IS EFFECTIVE PURSUANT TO GENERAL
INSTRUCTION A.(D), CHECK THE FOLLOWING BOX: [X]
SECURITIES ACT REGISTRATION STATEMENT FILE NUMBER TO WHICH THIS FORM RELATES:
333-36429
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT: COMMON
SHARES
ITEM 1. DESCRIPTION OF COMMON SHARES TO BE REGISTERED.
- ------- ---------------------------------------------------
The Description of the Registrant s Common Shares contained in the
Registration Statement on Form S-1, Registration No. 333-36429, and the
Description of the Registrant s Common Shares which will be contained in the
Prospectus which will be filed by the Registrant pursuant to Rule 424(b) under
the Securities Act of 1933, as amended, are hereby incorporated by reference.
ITEM 2. EXHIBITS.
- ------- ---------
The securities described herein are to be registered on the Nasdaq
National Market ( NASDAQ ), on which no other securities of the Registrant are
registered. Accordingly, the following Exhibits required in accordance with
Part II to the instructions as to Exhibits to Form 8-A have been or will be
filed with NASDAQ.
<TABLE>
<CAPTION>
<S> <C>
Exhibit
Number. Description of Exhibit
- ------- ----------------------------------------------------
1. . . Registration Statement on Form S-1, Registration No.
333-36429, as filed with the Securities and Exchange
Commission on September 26, 1997 under the
Securities Act of 1933, as amended.
Not Applicable.
2
3. . . Not Applicable.
4.1. . Second Restated Articles of Incorporation of
Bioanalytical Systems, Inc.
4.2. . Second Restated Bylaws of Bioanalytical Systems,
Inc.
4.3. . Letter Agreement by and among Bioanalytical
Systems, Inc., Primus Capital Fund II, L.P. and
Middlewest Ventures II, L.P.
5. . . Specimen copy of Bioanalytical Systems, Inc.
Common Share Certificate.
6. . . Not Applicable.
</TABLE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
BIOANALYTICAL SYSTEMS, INC.
By: /s/ Peter T. Kissinger
Peter T. Kissinger
President and Chief Executive Officer
Date: November 11, 1997
